Related Experiment Videos
Screening for consumptive coagulopathy in preeclampsia
J Metz1, R Cincotta, M Francis
1Department of Hematology/Immunology, Royal Women's Hospital, Melbourne, Australia.
Summary
Screening for consumptive coagulopathy in preeclampsia (PE) can be efficiently done using a combination of platelet count and activated partial thromboplastin time (APTT) tests. This practical approach aids in early detection and management.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Clinical Pathology
Background:
- Preeclampsia (PE) is a serious pregnancy complication.
- Consumptive coagulopathy can arise in PE, necessitating effective screening.
- Identifying cost-effective diagnostic profiles is crucial for clinical practice.
Purpose of the Study:
- To determine a practical and cost-effective panel of laboratory tests for screening consumptive coagulopathy in preeclampsia.
- To evaluate the utility of various coagulation parameters in PE patients.
Main Methods:
- Retrospective analysis of coagulation test results (platelet count, PT, APTT, fibrinogen, D-dimers) in 100 preeclampsia patients.
- Patients were categorized based on hypertension and proteinuria status.
Main Results:
- Elevated D-dimers (34%) and thrombocytopenia (14%) were the most frequent abnormalities.
- Prolonged activated partial thromboplastin time (APTT) occurred in 12% of patients.
- A significant proportion of patients with elevated D-dimers alone did not show evidence of factor consumption.
Conclusions:
- A combination of platelet count and activated partial thromboplastin time (APTT) offers a practical and cost-effective screening strategy for consumptive coagulopathy in preeclampsia.
- This combination may streamline diagnostic workups and improve patient management.